- PMID 19476376.
Adjei AA (June 2004). "Pemetrexed (ALIMTA), a
novel multitargeted antineoplastic agent".
Clinical Cancer Research. 10 (12 Pt 2): 4276s–4280s...
- AEE788 is a
multitargeted human epidermal receptor (HER) 1/2 and
vascular endothelial growth factor receptor (VEGFR) 1/2
receptor family tyrosine kinases...
-
Retrieved 29 June 2023.
Manegold C (August 2003). "Pemetrexed (Alimta, MTA,
multitargeted antifolate, LY231514) for
malignant pleural mesothelioma". Seminars...
-
Retrieved 16 July 2016.
Shabbir M,
Stuart R (March 2010). "Lestaurtinib, a
multitargeted tyrosine kinase inhibitor: from
bench to bedside".
Expert Opinion on...
-
supported .NET
Framework version of choice. This
feature is
called "
multitargeting". Any
given build of a project, however, can only
target one version...
- 2021.
Juarez M, Schcolnik-Cabrera A, Dueñas-Gonzalez A (2018). "The
multitargeted drug ivermectin: from an
antiparasitic agent to a
repositioned cancer...
- Tramontin, Tony; Marukian, Svetlana; Hamill,
Michael J. (2021). "A novel,
multitargeted endogenous metabolic modulator composition impacts metabolism, inflammation...
-
Sturniolo I, Kiss A, Kovács K, Demény M, et al. (September 2022). "The
multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2...
- oligonucleotides,
which induce ERG exon
skipping in
prostate cancer models,
multitargeted kinase inhibitors that
inhibit the PI3K with
other pathways including...
- DR, Wei RQ, et al. (April 2006). "Preclinical
activity of ABT-869, a
multitargeted receptor tyrosine kinase inhibitor".
Molecular Cancer Therapeutics....
